MIAMI, FL / ACCESSWIRE / April 15, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. GBSN, GENE, COOL, and ORPN have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Great Basin Scientific, Inc. (NASDAQ: GBSN) announced on Friday its Q1 revenues and customer acquisition results which has led to gains of 31.67% during Friday's morning trading session hitting highs of $6.07. Great Basin Scientific is a molecular diagnostics company. In their press release they reported the company saw a 59.4% increase in revenues over the first quarter of 2015. They also announced an 119.8% increase in their customer base. "We are extremely pleased with the Company's execution over the last 12 months, including our ability to significantly grow our customer base, develop and launch new tests, and the accelerating growth in our revenues," stated Ryan Ashton, Co-founder and Chief Executive Officer of Great Basin.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.
Genetic Technologies Limited (NASDAQ: GENE) is a molecular diagnostics company specializing in women's health over the last two trading days has seen an increase in trading volume which has led to a 10.84% price per share gain. The company's most recent announcement Genetic Technologies partnered with IndyCar's Pippa Mann to promote BREVAGenplus®, the Company's first-in-class, clinically validated risk assessment test for sporadic breast cancer.
Subscribe Now And Reserve A Spot To Receive Our First Alert Of April. Get Your Free Membership Now.
Majesco Entertainment Company (NASDAQ: COOL) is an innovative provider of downloadable games for the mass market. On Thursday 4/14/16, the company announced that it accepted subscription agreements with certain accredited investors for an above market registered direct offering. Over the last three trading sessions COOL has seen a price increase of 25.83% from lows on Tuesday of $0.751 to highs during Friday morning's trading session of $0.945.
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948
BioBlast Pharma Ltd. (NASDAQ: ORPN) is a clinical-stage, orphan disease-focused biotechnology company. The company announced Thursday 4/14/16 that they will present previously announced positive final results from its HOPEMD Phase 2 six-month open-label clinical study in patients with oculopharyngeal muscular dystrophy (OPMD) at the 2016 American Academy of Neurology (AAN) Annual Meeting, in Vancouver, Canada April 15-21. Since releasing the news, ORPN has seen a price spike of 31.51% seeing highs during Friday morning's trading session of $3.13. The stock has also seen an increase in trading volume Friday morning trading 3.7 million shares.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here
About TopNasdaqStocks.com
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Contact:
Top Nasdaq Stocks
news@topnasdaqstocks.com
SOURCE: Top Nasdaq Stocks
ReleaseID: 438872
